Aparito - a wholly owned subsidiary of Eli Lilly and Company, one of our Bayer G4A alumni companies, has been acquired by Eli Lilly and Company, marking a significant milestone in their journey. 🎉 A huge congratulations to the Aparito team! 🍾 We at Bayer G4A are proud to have supported your growth and are excited to see what the future holds for you.🙌 Check more details below 👇 : Looking forward to more innovative breakthroughs from Bayer G4A community! 🚀 #DigitalHealth #Innovation #HealthTech
Thanks to Development Bank of Wales and all others that supported us along the way. Too many to list all here. It’s been an epic adventure over the last 10 years. I’m now looking forward to the new opportunities of digitising clinical trials and all things #eCOA as part of Eli Lilly and Company